drugset / Trial / NCT01290354
Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to find out how much lapatinib can enter both normal brains and brains in which tumours secondary to breast cancer have developed.
Timeline
- Start
- 2011-09-12
- Primary completion
- 2013-03-18
- Completion
- 2013-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapatinib | Small molecule | 20 ug | Intravenous |
| Subject | Lapatinib | Small molecule | 1500 mg | Oral |